Document is current
Any future updates will be listed below
-
Authors
Grzywa, Tomasz M. https://orcid.org/0000-0002-1809-248X
Neeser, Alexandra
Ramasubramanian, Ranjani
Romanov, Anna https://orcid.org/0000-0002-1239-4946
Tannir, Ryan https://orcid.org/0009-0009-3979-7567
Mehta, Naveen K.
Cossette, Benjamin
Morgan, Duncan M. https://orcid.org/0000-0002-3253-1362
Goncalves, Beatriz
Sukaj, Ina
Bergaggio, Elisa https://orcid.org/0000-0002-9960-3674
Kadauke, Stephan https://orcid.org/0000-0003-2996-8034
Myers, Regina M.
Paruzzo, Luca https://orcid.org/0000-0002-6505-0194
Ghilardi, Guido
Cozzone, Austin
Schuster, Stephen J.
Frey, Noelle
Zhang, Libin
Yousefpour, Parisa
Abraham, Wuhbet
Suh, Heikyung
Ruella, Marco https://orcid.org/0000-0003-4301-5811
Grupp, Stephan A. https://orcid.org/0000-0001-8030-7595
Chiarle, Roberto https://orcid.org/0000-0003-1564-8531
Wittrup, K. Dane https://orcid.org/0000-0003-2398-5896
Ma, Leyuan https://orcid.org/0000-0002-0583-7470
Irvine, Darrell J. https://orcid.org/0000-0002-8637-1405
- License Information
-
More Information
Article History
Received: 17 February 2024
Accepted: 25 June 2025
First Online: 25 August 2025
Competing interests
: L.M. and D.J.I. are inventors on patents filed related to the amphiphile-mimotope vaccine technology (WO2021221782A1, WO2021221783A1), which has been licensed to Elicio Therapeutics. D.J.I. is a consultant and holds equity in Elicio Therapeutics. G.G. served as a scientific consultant for viTToria Biotherapeutics. M.R. holds patents related to CD19 CAR-T cells, served as a consultant for NanoString, Bristol Myers Squibb, GlaxoSmithKline, Scaylite, Bayer and AbClon, and receives research funding from AbClon, NanoString, Oxford NanoImaging, viTToria Biotherapeutics, CURIOX and Beckman Coulter. M.R. is the scientific founder of viTToria Biotherapeutics. The remaining authors declare no competing interests.
